Avantax Advisory Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$59.8K Buy
+11,815
New +$59.8K ﹤0.01% 2321